Revolutionary Technique Sends Healthy Mitochondria Exactly Where They’re Needed

Researchers developed MitoCatch, a binder-based system for targeted mitochondrial transplantation into specific human and mouse cell types.

The platform delivered healthy donor mitochondria to neurons and retinal cells, where they stayed functional and helped rescue damaged cells.

Tests found no detectable immune response, addressing a major safety concern for mitochondrial therapy.

The advance could improve precision treatment for disorders linked to energy failure, including Parkinson’s, Alzheimer’s, and heart failure.